Indication
Vaginal Dysbiosis
2 clinical trials
5 products
Clinical trial
Screen-and-treat Strategy for Vaginal Flora Abnormalities by Multiplex Molecular Biology Using POC Technology in Pregnant Women at High Risk of Preterm Birth: A Multicentre, Randomized Study (AUTOP2)Status: Not yet recruiting, Estimated PCD: 2027-03-01
Product
AzithromycineProduct
CeftriaxoneProduct
MetronidazoleProduct
ClotrimazoleClinical trial
Comparison Between Oral Clindamycin Vs Metronidazole for the Treatment of Abnormal Vaginal Flora in High Risk PregnanciesStatus: Recruiting, Estimated PCD: 2025-08-01
Product
Clindamycin